Interpretation of the important update of the Guideline for the prevention and treatment of hepatitis C (2022 edition).
10.3760/cma.j.cn501113-20230529-00233
- Author:
Hui Ying RAO
1
;
Lai WEI
2
Author Information
1. Peking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China.
2. Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.
- Publication Type:Journal Article
- Keywords:
Guideline interpretation;
Hepatitis C;
Prevention;
Treatment
- MeSH:
Humans;
Hepacivirus;
Hepatitis C/prevention & control*;
Mass Screening;
Asian People
- From:
Chinese Journal of Hepatology
2023;31(7):688-691
- CountryChina
- Language:Chinese
-
Abstract:
In the past 20 years, Chinese Medical Association had issued several versions of hepatitis C prevention and treatment guidelines. In the latest guidelines published in 2022, the Chinese Society of Hepatology and the Society of Infectious Diseases for the Chinese Medical Association organized experts to update their recommendations for hepatitis C screening and treatment. The updated key points on prevention, diagnosis, and treatment proposed in the guidelines are now interpreted, aiming to provide reference for more effective clinical application of the guidelines.
